Related Experiment Video
Updated: Mar 17, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
A novel ER-microtubule-binding protein, ERLIN2, stabilizes Cyclin B1 and regulates cell cycle progression
Xuebao Zhang1, Juan Cai1, Ze Zheng1
1Center for Molecular Medicine and Genetics, Wayne State University School of Medicine , Detroit, MI, USA.
Abstract:
The gene encoding endoplasmic reticulum (ER) lipid raft-associated protein 2 (ERLIN2) is amplified in human breast cancers. ERLIN2 gene mutations were also found to be associated with human childhood progressive motor neuron diseases. Yet, an understanding of the physiological function and mechanism for ERLIN2 remains elusive. In this study, we reveal that ERLIN2 is a spatially and temporally regulated ER-microtubule-binding protein that has an important role in cell cycle progression by interacting with and stabilizing the mitosis-promoting factors. Whereas ERLIN2 is highly expressed in aggressive human breast cancers, during normal development ERLIN2 is expressed at the postnatal stage and becomes undetectable in adulthood. ERLIN2 interacts with the microtubule component α-tubulin, and this interaction is maximal during the cell cycle G2/M phase where ERLIN2 simultaneously interacts with the mitosis-promoting complex Cyclin B1/Cdk1. ERLIN2 facilitates K63-linked ubiquitination and stabilization of Cyclin B1 protein in G2/M phase. Downregulation of ERLIN2 results in cell cycle arrest, represses breast cancer proliferation and malignancy and increases sensitivity of breast cancer cells to anticancer drugs. In summary, our study revealed a novel ER-microtubule-binding protein, ERLIN2, which interacts with and stabilizes mitosis-promoting factors to regulate cell cycle progression associated with human breast cancer malignancy.
Insights
Endoplasmic reticulum protein 2 (ERLIN2) binds microtubules and stabilizes cell cycle factors, impacting breast cancer malignancy. Its downregulation halts cancer cell proliferation and drug resistance.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The gene for endoplasmic reticulum (ER) lipid raft-associated protein 2 (ERLIN2) is amplified in human breast cancers.
- ERLIN2 mutations are linked to childhood progressive motor neuron diseases, but its function is unclear.
Purpose of the Study:
- To elucidate the physiological function and mechanism of ERLIN2.
- To investigate ERLIN2's role in cell cycle regulation and breast cancer.
Main Methods:
- Investigated ERLIN2's interaction with ER and microtubules.
- Analyzed ERLIN2's role in cell cycle progression, specifically G2/M phase.
- Examined ERLIN2's interaction with Cyclin B1/Cdk1 complex.
- Assessed the impact of ERLIN2 downregulation on breast cancer cells.
Main Results:
- ERLIN2 is a spatially and temporally regulated ER-microtubule-binding protein.
- ERLIN2 interacts with α-tubulin and stabilizes mitosis-promoting factors like Cyclin B1/Cdk1 during G2/M phase.
- ERLIN2 facilitates K63-linked ubiquitination and stabilization of Cyclin B1.
- ERLIN2 is highly expressed in aggressive breast cancers but downregulated in adult development.
- ERLIN2 downregulation causes cell cycle arrest, reduces breast cancer proliferation and malignancy, and enhances drug sensitivity.
Conclusions:
- ERLIN2 is a novel ER-microtubule-binding protein crucial for cell cycle progression.
- ERLIN2 stabilizes mitosis-promoting factors, regulating cell cycle and impacting breast cancer malignancy.
- Targeting ERLIN2 may offer therapeutic strategies for breast cancer.
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System

